3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
29
Genitourinary
4
Gastrointestinal
3
Dermatologic
3
Head & Neck
2
Gynecologic
2
CNS
2
Breast
2
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Endocrine
1
Conditions
Sarcoma
4
Gliosarcoma
4
Glioblastoma
4
Brain Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neoplasm Metastasis
2
Melanoma
2
Liposarcoma
2
Endometrial Neoplasms
2
Carcinosarcoma
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Rhabdomyosarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Platinum-Refractory Fallopian Tube Carcinoma
1
Pharyngeal Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Neoplasms
1
Interventions
pembrolizumab
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Cyclophosphamide
5
Radiosurgery
3
Oncolytic Virotherapy
3
Nivolumab
3
Injections
3
Gemcitabine
3
Drug Therapy
3
Biopsy
3
fludarabine
2
belinostat
2
Riluzole
2
Paclitaxel
2
Ipilimumab
2
Filgrastim
2
Docetaxel
2
Cisplatin
2
Celecoxib
2
Carboplatin
2
Bortezomib
2
Blood Specimen Collection
2
Amifostine
2
AH 111585
2
tislelizumab
1
spartalizumab
1
seribantumab
1
selpercatinib
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Immunoglobulin G
×
Sarcoma
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled